| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nasturtium (Tropaeolum majus) — Edible medicinal plant and functional food characterized by high concentrations of the benzyl glucosinolate glucotropaeolin. When plant tissue is disrupted, endogenous myrosinase hydrolyzes glucotropaeolin to benzyl isothiocyanate (BITC), a bioactive isothiocyanate with antimicrobial, anti-inflammatory, metabolic, and anticancer activity. Product class: Food Source / medicinal herb / glucosinolate-rich plant. Major bioactive compounds: Glucotropaeolin (benzyl glucosinolate), benzyl isothiocyanate (BITC), polyphenols, anthocyanins, carotenoids, vitamin C, and other phenolic and volatile compounds. Cancer relevance: Primarily preclinical. Much of the anticancer activity attributed to nasturtium is linked to its conversion of glucotropaeolin to benzyl isothiocyanate. BITC has demonstrated antiproliferative, pro-apoptotic, cell-cycle inhibitory, autophagy-modulating, anti-invasive, and antimetastatic activity across multiple experimental cancer models. Typical mechanisms: BITC formation ↑; ROS modulation; apoptosis ↑; autophagy modulation; cell-cycle arrest ↑; proliferation ↓; AKT signaling ↓ in selected models; migration/invasion ↓; detoxification and NRF2-associated signaling modulation. Clinical relevance: Nasturtium herb has been clinically studied primarily in combination with horseradish root for urinary and respiratory tract infections. Randomized trials support activity against recurrent uncomplicated urinary tract infections, although these combination studies cannot attribute the full clinical effect specifically to nasturtium. Bioavailability: Human studies demonstrate metabolism and systemic exposure to benzyl-isothiocyanate-derived metabolites after consumption of Tropaeolum majus, supporting conversion of plant glucotropaeolin to biologically available BITC-related metabolites. Processing consideration: Bioactive composition is strongly affected by processing because myrosinase converts glucotropaeolin to BITC. Heat can inactivate myrosinase, whereas crushing or chopping fresh tissue promotes hydrolysis. Commercial extracts may contain substantially different glucotropaeolin and BITC levels depending on processing. Nasturtium (Tropaeolum majus) — An edible medicinal plant, also called Indian cress or garden nasturtium, whose principal mechanistically relevant phytochemical system is the benzyl glucosinolate glucotropaeolin and its myrosinase-generated hydrolysis product benzyl isothiocyanate (BITC). It is formally classified as a Food Source / medicinal herb / glucosinolate-rich plant. Standard abbreviations include Nast for nasturtium and BITC for its major active isothiocyanate. Leaves, flowers, stems, and seeds are edible, but glucosinolate content and conversion to BITC vary substantially with plant tissue, processing, storage, and myrosinase activity. Most experimental anticancer activity attributed to nasturtium is mechanistically attributable to BITC rather than to intact whole-plant material. Primary mechanisms (ranked):
Bioavailability / PK relevance: Human intervention studies confirm gastrointestinal conversion and systemic absorption after oral nasturtium. Following ingestion of glucotropaeolin-rich freeze-dried material, BITC-related glutathione, cysteinylglycine, cysteine, and N-acetylcysteine conjugates appear in plasma and urine. BITC-related metabolites can remain detectable in plasma for many hours, while protein conjugates and volatile BITC-related compounds may persist for up to approximately 48 hours. Exposure depends strongly on glucotropaeolin content and active myrosinase; heating can inactivate myrosinase, whereas disruption of fresh tissue promotes glucosinolate hydrolysis. Recent analytical work also indicates that commercial processed extracts may contain very low or highly variable glucotropaeolin and BITC concentrations. In-vitro vs systemic exposure relevance: Anticancer studies commonly expose cultured cells directly to low-micromolar or higher concentrations of purified BITC. Human consumption of nasturtium clearly produces systemic BITC-derived metabolites, but circulating exposure is dominated by conjugated and protein-bound species and cannot presently be assumed to reproduce continuous free-BITC concentrations used in cell culture. Therefore, direct translation of in-vitro anticancer concentrations to dietary nasturtium exposure is not established. Clinical evidence status: Cancer: preclinical only; evidence consists primarily of cell culture, xenograft, and other animal studies of purified BITC rather than trials of nasturtium for cancer treatment. Non-cancer: human PK/intervention studies and randomized clinical trials exist. A standardized nasturtium-herb plus horseradish-root medicinal product has undergone randomized controlled and phase III/IV studies for recurrent urinary tract infection and respiratory disease, including a 2026 placebo-controlled phase III trial showing reduced recurrence of uncomplicated cystitis. These combination trials support clinical activity of an isothiocyanate-containing phytomedicine but cannot establish the independent contribution of nasturtium. Safety / translation: Culinary nasturtium is widely consumed as an edible plant, and clinical combination preparations have generally shown acceptable tolerability in studied populations. However, anticancer doses of purified BITC should not be inferred from culinary exposure: high-dose BITC caused toxicity in early animal antitumor experiments. Reactive isothiocyanates also form glutathione and protein conjugates, making dose, formulation, tissue exposure, and processing important determinants of both efficacy and toxicity. Nasturtium and BITC Mechanisms
P: 0–30 min R: 30 min–3 hr G: >3 hr |
| - | Study, | UTI, | NA |
| - | Analysis, | Inf, | NA |
| 9214- | Nast, | New Contributions to Deepen the Quality-Based Safety Assessment in the Consumption of Edible Nasturtium Flowers-The Role of Volatilome |
| - | Analysis, | Nor, | NA |
| - | Trial, | UTI, | NA |
| 9216- | Nast, | A monocentric, randomized, double-blind, controlled crossover trial of nasturtium (Tropaeolum majus) on the lipid regulator prostaglandin E2 |
| - | Trial, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:532 Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid